Literature DB >> 18683884

What potential role is there for medication treatment in anorexia nervosa?

Scott J Crow1, James E Mitchell, James D Roerig, Kristine Steffen.   

Abstract

OBJECTIVE: To review selected issues regarding the development of drug treatments for anorexia nervosa (AN).
METHOD: The existing pharmacotherapy literature for AN is reviewed, and the theoretical and practical considerations are discussed.
RESULTS: A very wide variety of drugs have been examined in AN, generally with negative results. There are a number of potential reasons for this finding, including compliance, nutritional deficits, selection of the wrong targets or the wrong outcome measures, use of monotherapy, lack of animal models, or factors intrinsic to AN.
CONCLUSION: Pharmacotherapy provides little benefit in the treatment of AN at present. Several strategies might lead to the identification of more effective agents, including new measurement strategies, identification of novel pharmacologic targets, and consideration of a clinical trials network. 2008 by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18683884     DOI: 10.1002/eat.20576

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  16 in total

1.  What can cognitive neuroscience teach us about anorexia nervosa?

Authors:  Amelia Kidd; Joanna Steinglass
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

Review 2.  Biological therapies for eating disorders.

Authors:  James E Mitchell; James Roerig; Kristine Steffen
Journal:  Int J Eat Disord       Date:  2013-07       Impact factor: 4.861

3.  Fear of food as a treatment target: exposure and response prevention for anorexia nervosa in an open series.

Authors:  Joanna Steinglass; Anne Marie Albano; H Blair Simpson; Kenneth Carpenter; Janet Schebendach; Evelyn Attia
Journal:  Int J Eat Disord       Date:  2011-05-03       Impact factor: 4.861

4.  Treatment of Adolescent Eating Disorders: Progress and Challenges.

Authors:  James Lock
Journal:  Minerva Psichiatr       Date:  2010-09

5.  A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.

Authors:  Jennifer Hagman; Jane Gralla; Eric Sigel; Swan Ellert; Mindy Dodge; Rick Gardner; Teri O'Lonergan; Guido Frank; Marianne Z Wamboldt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-08-05       Impact factor: 8.829

Review 6.  Motivation to eat and not to eat - The psycho-biological conflict in anorexia nervosa.

Authors:  Guido K W Frank; Marisa C DeGuzman; Megan E Shott
Journal:  Physiol Behav       Date:  2019-04-10

7.  Psychotropic medications in adult and adolescent eating disorders: clinical practice versus evidence-based recommendations.

Authors:  David M Garner; Michael L Anderson; Christopher D Keiper; Rachel Whynott; Lisa Parker
Journal:  Eat Weight Disord       Date:  2016-02-01       Impact factor: 4.652

8.  Current and emerging directions in the treatment of eating disorders.

Authors:  Tiffany A Brown; Pamela K Keel
Journal:  Subst Abuse       Date:  2012-03-29

9.  Recent advances in therapies for the eating disorders.

Authors:  Glenn Waller
Journal:  F1000 Med Rep       Date:  2009-05-08

10.  Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders.

Authors:  James M Greenblatt; Craig Sussman; Mariko Jameson; Lee Yuan; Daniel A Hoffman; Dan V Iosifescu
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.